Medicus Pharma Ltd.
MDCX
$0.30
-$0.04-10.68%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 134.19% | 183.83% | 101.01% | 125.12% | -37.28% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 117.29% | 187.41% | 69.29% | 200.24% | 0.30% |
| Operating Income | -117.29% | -187.41% | -69.29% | -200.24% | -0.30% |
| Income Before Tax | -326.04% | -818.76% | -70.00% | -198.84% | -156.55% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -326.04% | -818.76% | -70.00% | -198.84% | -156.55% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -326.04% | -818.76% | -70.00% | -198.84% | -156.55% |
| EBIT | -117.29% | -187.41% | -69.29% | -200.24% | -0.30% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -160.28% | -369.19% | 2.79% | -97.16% | -83.49% |
| Normalized Basic EPS | -158.20% | -161.12% | 5.94% | -97.20% | -128.29% |
| EPS Diluted | -421.88% | -369.19% | 2.79% | -97.16% | -83.49% |
| Normalized Diluted EPS | -158.20% | -161.12% | 5.94% | -97.20% | -128.29% |
| Average Basic Shares Outstanding | 63.67% | 95.82% | 74.88% | 51.55% | 39.84% |
| Average Diluted Shares Outstanding | 63.67% | 95.82% | 74.88% | 51.55% | 39.84% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |